Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: A single case study

American Journal of Therapeutics

Volumn 12, Issue 5, 2005, Pages 467-468

  Ivanco, Larry S ^a   Bohnen, Nicolaas I ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Donepezil; Hypersexual behavior; Parkinson disease

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; CITALOPRAM; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; NEUROLEPTIC AGENT; PERGOLIDE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; COGNITIVE DEFECT; COMPULSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MONITORING; DRUG TOLERABILITY; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL DEVIATION; TREATMENT OUTCOME;

AMANTADINE; CARBIDOPA; CHOLINESTERASE INHIBITORS; DOPAMINE AGENTS; DRUG THERAPY, COMBINATION; HUMANS; INDANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PERGOLIDE; PIPERIDINES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 26844469659     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000151861.59698.26     Document Type: Article

References (9)

1. Uitti R, Tanner C, Rajput A, et al. Hypersexuality with anti-parkinsonian therapy. Clin Neuropharmacol. 1989;12:375-383.
2. Brown R, Jahanshahi M, Quinn N, et al. Sexual function in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry. 1990;53:480-486.
3. Jimenez-Jimenez F, Sayed Y, Garcia-Soldevilla M, et al. Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother. 2002;36:1178-1179.
4. Menza M. Psychiatric aspects of Parkinson's disease. Psychiatr Ann. 2002;32:99-104.
5. Kanovsky P, Bares M, Pohanka M, et al. Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease. J Neurol. 2002; 249:112-114.
6. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with Dopamine agonist therapy in Parkinson's disease. Neurology. 2003;61:422-423.
7. Montastruc J, Schmitt L, Bagheri H. Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine. Rev Neurol (Paris). 2003;159: 441-443.
8. Bedard M, Pillon B, Dubois B, et al. Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome. Brain Cogn. 1999;40:289-313.
9. Green J, McDonald WM, Vitek JL, et al. Cognitive impairments in advanced PD without dementia. Neurology. 2002; 59:1320-1324.